KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $647.8 million.

  • Dynavax Technologies' Cash & Current Investments fell 1520.66% to $647.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $647.8 million, marking a year-over-year decrease of 1520.66%. This contributed to the annual value of $713.8 million for FY2024, which is 383.51% down from last year.
  • As of Q3 2025, Dynavax Technologies' Cash & Current Investments stood at $647.8 million, which was down 1520.66% from $613.7 million recorded in Q2 2025.
  • Dynavax Technologies' Cash & Current Investments' 5-year high stood at $764.0 million during Q3 2024, with a 5-year trough of $232.7 million in Q1 2021.
  • For the 5-year period, Dynavax Technologies' Cash & Current Investments averaged around $601.4 million, with its median value being $647.8 million (2025).
  • In the last 5 years, Dynavax Technologies' Cash & Current Investments soared by 23080.66% in 2021 and then plummeted by 1656.89% in 2025.
  • Over the past 5 years, Dynavax Technologies' Cash & Current Investments (Quarter) stood at $545.9 million in 2021, then grew by 14.37% to $624.4 million in 2022, then increased by 18.88% to $742.3 million in 2023, then dropped by 3.84% to $713.8 million in 2024, then decreased by 9.25% to $647.8 million in 2025.
  • Its Cash & Current Investments was $647.8 million in Q3 2025, compared to $613.7 million in Q2 2025 and $661.3 million in Q1 2025.